Hipertansif Aciller

Mills KT, Bundy JD, Kelly TN, et al. Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies From 90 Countries. Circulation, 2016 Aug 9;134(6):441-50. Doi: 10.1161/CIRCULATIONAHA.115.018912
Blacher J, Levy BI, Mourad JJ, et al. From epidemiological transition to modern cardiovascular epidemiology: hypertension in the 21st century. The Lancet, 2016 Jul;388(10043):530–2. Doi: 10.1016/S0140-6736(16)00002-7
Chobanian A V., Bakris GL, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension, 2003 Dec;42(6):1206–52. Doi: 10.1161/01.HYP.0000107251.49515.c2
Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). European Heart Journal, 2018 Sep 1;39(33):3021–104. Doi: 10.1093/eurheartj/ehy339
Van Den Born BJH, Lip GYH, Brguljan-Hitij J, et al. ESC Council on hypertension position document on the management of hypertensive emergencies. European Heart Journal Cardiovascular Pharmacotheraphy, 2019 Jan 1;5(1):37–46. Doi: 10.1093/ehjcvp/pvy032
Pinna G, Pascale C, Fornengo P, et al. Hospital admissions for hypertensive crisis in the emergency departments: a large multicenter Italian study. PLOS One, 2014 Apr 2;9(4). Doi: 10.1371/journal.pone.0093542
Deshmukh A, Kumar G, Kumar N, et al. Effect of Joint National Committee VII report on hospitalizations for hypertensive emergencies in the United States. American Journal of Cardiolology, 2011 Nov 1;108(9):1277–82. Doi: 10.1016/j.amjcard.2011.06.046
Janke AT, McNaughton CD, et al. Trends in the Incidence of Hypertensive Emergencies in US Emergency Departments From 2006 to 2013. Journal of the American Heart Association, 2016 Dec 1;5(12). Doi: 10.1161/JAHA.116.004511
Opie LH, Seedat YK. Hypertension in sub-Saharan African populations. Circulation, 2005 Dec;112(23):3562–8. Doi: 10.1161/CIRCULATIONAHA.105.539569
Van Den Born BJH, Koopmans RP, Groeneveld JO, et al. Ethnic disparities in the incidence, presentation and complications of malignant hypertension. Journal of Hypertension, 2006;24(11):2299–304. Doi: 10.1097/01.hjh.0000249710.21146.38
Vaughan CJ, Delanty N. Hypertensive emergencies. Lancet, 2000 Jul 29;356(9227):411–7. Doi: 10.1016/S0140-6736(00)02539-3
Chester EM, Agamanolis DP, Betty Q, et al. Hypertensive encephalopathy: a clinicopathologic study of 20 cases. Neurology, 1978;28(9 Pt 1):928–39. Doi: 10.1212/wnl.28.9.928
Cremer A, Amraoui F, Lip GYH, et al. From malignant hypertension to hypertension-MOD: a modern definition for an old but still dangerous emergency. Journal of Human Hypertension, 2016 Aug 1;30(8):463–6. Doi: 10.1038/jhh.2015.112
Van Den Born BJH, Löwenberg EC, Van Der Hoeven N V., et al. Endothelial dysfunction, platelet activation, thrombogenesis and fibrinolysis in patients with hypertensive crisis. Journal of Hypertension, 2011;29(5):922–7. Doi: 10.1097/HJH.0b013e328345023d
Grassi D, O’Flaherty M, Pellizzari M, et al. Hypertensive urgencies in the emergency department: evaluating blood pressure response to rest and to antihypertensive drugs with different profiles. The Journal of Clinical Hypertension, 2008;10(9):662–7. Doi: 10.1111/j.1751-7176.2008.00001.x
Patel KK, Young L, Howell EH, et al. Characteristics and Outcomes of Patients Presenting With Hypertensive Urgency in the Office Setting. JAMA Internal Medicine, 2016 Jul 1;176(7):981–8. Doi: 10.1001/jamainternmed.2016.1509
Lip GYH, Beevers M, Beevers G. The failure of malignant hypertension to decline: a survey of 24 years’ experience in a multiracial population in England. Journal of Hypertension, 1994 Nov;12(11):1297-1305.
van den Born BJH, Koopmans RP, van Montfrans GA. The renin-angiotensin system in malignant hypertension revisited: plasma renin activity, microangiopathic hemolysis, and renal failure in malignant hypertension. American Journal of Hypertension, 2007 Aug;20(8):900–6. Doi: 10.1016/j.amjhyper.2007.02.018
Lip GYH, Edmunds E, Hee FLLS, et al. A cross-sectional, diurnal, and follow-up study of platelet activation and endothelial dysfunction in malignant phase hypertension. American Journal of Hypertension, 2001;14(8 Pt 1):823–8. Doi: 10.1016/s0895-7061(01)02045-3
Victor RG, Libby P, Systemic Hypertension. In: Zipes DP, Libby P, Bonow RO, Mann DL, Tomaselli GF, Braunwald E. (eds.) Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine, Single Volume 11th Edition. Philedelphia: Elsevier; 2018 p. 2342-2346.
Katz JN, Gore JM, Amin A, et al. Practice patterns, outcomes, and end-organ dysfunction for patients with acute severe hypertension: The Studying the Treatment of Acute hyperTension (STAT) Registry. American Heart Journal, 2009;158(4):599-606.e1. Doi: 10.1016/j.ahj.2009.07.020
Mancia G, Kreutz R, Brunström M, et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). Journal of Hypertension, 2023 Dec 1;41(12):1874–2071. Doi: 10.1097/HJH.0000000000003480
Neskovic AN, Hagendorff A, Lancellotti P, et al. Emergency echocardiography: the European Association of Cardiovascular Imaging recommendations. European Heart Journal: Cardiovascular Imaging, 2013 Jan;14(1):1–11. Doi: 10.1093/ehjci/jes193
Grossman E, Messerli FH, Grodzicki T, et al. Should a Moratorium Be Placed on Sublingual Nifedipine Capsules Given for Hypertensive Emergencies and Pseudoemergencies? JAMA, 1996 Oct 23;276(16):1328–31. Doi: 10.1001/jama.1996.03540160050032
Haas DC, Streeten DHP, Kim RC, et al. Death from cerebral hypoperfusion during nitroprusside treatment of acute angiotensin-dependent hypertension. American Journal of Medicine, 1983;75(6):1071–6. Doi: 10.1016/0002-9343(83)90891-4
Ledingham JGG, Rajagopalan B. Cerebral Complications in the Treatment of Accelerated Hypertension. QJM: An International Journal of Medicine,1979 Jan 1;48(1):25–41. Doi: 10.1093/oxfordjournals.qjmed.a067564
Wilson DJ, Wallin JD, Vlachakis ND, et al. Intravenous labetalol in the treatment of severe hypertension and hypertensive emergencies. American Journal of Medicine, 1983 Oct 17;75(4A):95–102. Doi: 10.1016/0002-9343(83)90141-9
Hirschl MM, Binder M, Bur A, et al. Safety and efficacy of urapidil and sodium nitroprusside in the treatment of hypertensive emergencies. Intensive Care Medicine, 1997;23(8):885–8. Doi: 10.1007/s001340050426
Clifton GG, Cook ME, Bienvenu GS, et al. Intravenous nicardipine in severe systemic hypertension. American Journal of Cardiology, 1989 Oct 17;64(15). Doi: 10.1016/0002-9149(89)90975-2
Gosse P, Coulon P, Papaioannou G, et al. Impact of malignant arterial hypertension on the heart. Journal of Hypertension, 2011;29(4):798–802. Doi: 10.1097/HJH.0b013e3283430b12
Immink R V., Van Den Born BJH, Van Montfrans GA, et al. Cerebral hemodynamics during treatment with sodium nitroprusside versus labetalol in malignant hypertension. Hypertension, 2008 Aug;52(2):236–40. Doi: Available from: https://pubmed.ncbi.nlm.nih.gov/18606905/
Chiariello M, Gold HK, Leinbach RCet al. Comparison between the effects of nitroprusside and nitroglycerin on ischemic injury during acute myocardial infarction. Circulation, 1976;54(5):766–73. Doi: 10.1161/01.cir.54.5.766
Frishman WH, Strom JA, Kirschner M, et al. Labetalol therapy in patients with systemic hypertension and angina pectoris: effects of combined alpha and beta adrenoceptor blockade. American Journal of Cardiology 1981;48(5):917–28. Doi: 10.1016/0002-9149(81)90359-3
Marx PG, Reid DS. Labetalol infusion in acute myocardial infarction with systemic hypertension. British Journal of Clinical Pharmacology, 1979 Apr;8 Suppl 2(2 S):233S-8S. Doi: 10.1111/j.1365-2125.1979.tb04787.x
Durrer JD, Lie KI, van Capelle FJL, et al. Effect of sodium nitroprusside on mortality in acute myocardial infarction. New England Journal of Medicine, 1982 May 13;306(19):1121–8. Doi: 10.1056/NEJM198205133061901
Gregorini L, Marco J, Palombo C, et al. Postischemic left ventricular dysfunction is abolished by alpha-adrenergic blocking agents. Journal of the American College of Cardiology, 1998 Apr;31(5):992–1001. Doi: 10.1016/s0735-1097(98)00055-2
Gregorini L, Marco J, Kozàkovà M, et al. Alpha-adrenergic blockade improves recovery of myocardial perfusion and function after coronary stenting in patients with acute myocardial infarction. Circulation, 1999 Feb;99(4):482–90. Doi: 10.1161/01.cir.99.4.482
Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal, 2016 Jul 14;37(27):2129–2200m. Doi: 10.1093/eurheartj/ehw128
Schreiber W, Woisetschläger C, Binder M, et al. The nitura study--effect of nitroglycerin or urapidil on hemodynamic, metabolic and respiratory parameters in hypertensive patients with pulmonary edema. Intensive Care Medicine, 1998;24(6):557–63. Doi: 10.1007/s001340050615
Ulici A, Jancik J, Lam TS, et al. Clevidipine versus sodium nitroprusside in acute aortic dissection: A retrospective chart review. American Journal of Emergency Medicine, 2017 Oct 1;35(10):1514–8. Doi: 10.1016/j.ajem.2017.06.030
Rodriguez-Luna D, Piñeiro S, Rubiera M, et al. Impact of blood pressure changes and course on hematoma growth in acute intracerebral hemorrhage. European Journal of Neurology, 2013 Sep;20(9):1277–83. Doi: 10.1111/ene.12180
Anderson CS, Heeley E, Huang Y, Wang J, et al. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. New England Journal of Medicine, 2013 Jun 20;368(25):2355–65. Doi: 10.1056/NEJMoa1214609
Qureshi AI, Palesch YY, Barsan WG, et al. Intensive Blood-Pressure Lowering in Patients with Acute Cerebral Hemorrhage. New England Journal of Medicine, 2016 Sep 15;375(11):1033–43. Doi: 10.1056/NEJMoa1603460
Moullaali TJ, Wang X, Martin RH, et al. Blood pressure control and clinical outcomes in acute intracerebral haemorrhage: a preplanned pooled analysis of individual participant data. Lancet Neurology, 2019 Sep 1;18(9):857–64. Doi: 10.1016/S1474-4422(19)30196-6
Sandset EC, Anderson CS, Bath PM, et al. European Stroke Organisation (ESO) guidelines on blood pressure management in acute ischaemic stroke and intracerebral haemorrhage. European Stroke Journal, 2021 Jun;6(2):II–II. Doi: 10.1177/23969873211026998
Wang X, Di Tanna GL, Moullaali TJ, et al. J-shape relation of blood pressure reduction and outcome in acute intracerebral hemorrhage: A pooled analysis of INTERACT2 and ATACH-II individual participant data. International Journal of Stroke, 2022 Dec 1;17(10):1129–36. Doi: 10.1177/17474930211064076
Moullaali TJ, Wang X, Sandset EC, et al. Early lowering of blood pressure after acute intracerebral haemorrhage: a systematic review and meta-analysis of individual patient data. Journal of Neurology, Neurosurgery, and Psychiatry, 2022 Jan 1;93(1):6–13. Doi: 10.1136/jnnp-2021-327195
Tsivgoulis G, Katsanos AH, Butcher KS, et al. Intensive blood pressure reduction in acute intracerebral hemorrhage: a meta-analysis. Neurology, 2014 Oct 1;83(17):1523–9. Doi: 10.1212/WNL.0000000000000917
Lobanova I, Qureshi AI, Huang W, et al. Outcomes of Intensive Systolic Blood Pressure Reduction in Patients With Intracerebral Hemorrhage and Excessively High Initial Systolic Blood Pressure: Post Hoc Analysis of a Randomized Clinical Trial. JAMA Neurology, 2020 Nov 1;77(11):1355–65. Doi: 10.1001/jamaneurol.2020.3075
Britton M, Carlsson A, de Faire U. Blood pressure course in patients with acute stroke and matched controls. Stroke, 1986;17(5):861–4. Doi: 10.1161/01.str.17.5.861
Lee M, Ovbiagele B, Hong KS, et al. Effect of Blood Pressure Lowering in Early Ischemic Stroke: Meta-Analysis. Stroke, 2015 Jul 4;46(7):1883–9. Doi: 10.1161/STROKEAHA.115.009552
Zhao R, Liu F Di, Wang S, et al. Blood Pressure Reduction in the Acute Phase of an Ischemic Stroke Does Not Improve Short- or Long-Term Dependency or Mortality: A Meta-Analysis of Current Literature. Medicine, 2015 Jun 7;94(23):e896. Doi: 10.1097/MD.0000000000000896
Sandset EC, Murray GD, Bath PMW, et al. Relation between change in blood pressure in acute stroke and risk of early adverse events and poor outcome. Stroke, 2012 Aug;43(8):2108–14. Doi: 10.1161/STROKEAHA.111.647362
Wu W, Huo X, Zhao X, et al. Relationship between Blood Pressure and Outcomes in Acute Ischemic Stroke Patients Administered Lytic Medication in the TIMS-China Study. PLOS One, 2016 Feb 1;11(2). Doi: 10.1371/journal.pone.0144260
Ahmed N, Wahlgren N, Brainin M, et al. Relationship of Blood Pressure, Antihypertensive Therapy, and Outcome in Ischemic Stroke Treated With Intravenous Thrombolysis. Stroke, 2009 Jul 1;40(7):2442–9. Doi: 10.1161/STROKEAHA.109.548602
Berge E, Whiteley W, Audebert H, et al. European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke. European Stroke Journal, 2021 Mar 1;6(1):I–LXII. Doi: 10.1177/2396987321989865
Katsanos AH, Malhotra K, Ahmed N, et al. Blood Pressure After Endovascular Thrombectomy and Outcomes in Patients With Acute Ischemic Stroke: An Individual Patient Data Meta-analysis. Neurology, 2022 Jan 18;98(3):E291–301. Doi: 10.1212/WNL.0000000000013049
Yang P, Song L, Zhang Y, et al. Intensive blood pressure control after endovascular thrombectomy for acute ischaemic stroke (ENCHANTED2/MT): a multicentre, open-label, blinded-endpoint, randomised controlled trial. Lancet, 2022 Nov 5;400(10363):1585–96. Doi: 10.1016/S0140-6736(22)01882-7
Boehrer JD, Moliterno DJ, Willard JE, et al. Influence of labetalol on cocaine-induced coronary vasoconstriction in humans. American Journal of Medicine, 1993;94(6):608–10. Doi: 10.1016/0002-9343(93)90212-8
Boutros AR, Bravo EL, Zanettin G, et al. Perioperative management of 63 patients with pheochromocytoma. Cleveland Clinic Journal of Medicine, 1990;57(7):613–7. Doi: 10.3949/ccjm.57.7.613
Briggs RSJ, Birtwell AJ, Pohl JEF. Hypertensive response to labetalol in phaeochromocytoma. Lancet, 1978 May 13;1(8072):1045–6. Doi: 10.1016/s0140-6736(78)90772-9
González R, Morales E, Segura J, et al. Long-term renal survival in malignant hypertension. Nephrology Dialysis Transplantation, 2010 Oct];25(10):3266–72. Doi: 10.1093/ndt/gfq143